Promising Disease Markers in Amyotrophic Lateral Sclerosis Promising Disease Markers in Amyotrophic Lateral Sclerosis
Researchers conducted a systematic review and meta-analysis of nerve excitability index studies in humans to uncover indices capable of identifying patients with amyotrophic lateral sclerosis.First Look (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 23, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Simple DNA test could detect common neurological disorders, study says
Exclusive: whole genome sequencing could end ‘diagnostic odyssey’ of multiple tests that still do not give precise diagnosisA simple test could end years of uncertainty for people with relatively common neurological conditions, new research has found.Historically, obtaining a definitive diagnosis for conditions including Huntingdon ’s disease and some forms of amyotrophic lateral sclerosis has been difficult, because, although the cause of the symptoms is genetic, knowing which test to carry out has resulted in delays of many years.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 17, 2022 Category: Science Authors: Linda Geddes Tags: Genetics Health NHS Science Biology Source Type: news
Brain Network Fingerprints Predict Impairment in Amyotrophic Lateral Sclerosis Brain Network Fingerprints Predict Impairment in Amyotrophic Lateral Sclerosis
New approach allows for subject-specific characterization of the disease.First Look (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 10, 2022 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news
Biogen's former R & D boss resurfaces on board of California biotech
Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 10, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news
Chance meeting five years ago leads to biotech startup CEO landing a Biogen biggie for her board
Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 8, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news
What Considerations Are There in Prescribing a Medical Cannabis Card?
Discussion
Cannabis is a plant which has many pharmacologically active compounds with THC or tetrahydrocannabinol and cannabidiol (CBD) being the most studied. For this case, medical cannabis will be used to describe different forms of the plant used to pharmacologically treat a variety of medical conditions.
Medical cannabis has been proposed and mainly studied in adult populations. Qualifying conditions for use of medical cannabis in this author’s US state currently include: ”
Cancer – if the illness or its treatment produces one or more of the following: severe or chronic pain, nausea or severe vomitin...
Source: PediatricEducation.org - January 31, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Long-Term Adjunctive Edaravone for ALS: Latest Findings Long-Term Adjunctive Edaravone for ALS: Latest Findings
Adding IV edaravone to riluzole for a year provides no additional benefit in terms of amyotrophic lateral sclerosis progression, time to ventilation, or survival versus riluzole alone, new research shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 17, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Nine Square Therapeutics Appoints Robert Paul as CEO
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-mole... Biopharmaceuticals, Neurology, Personnel Nine Square Therapeutics, Parkinson's disease, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Three additional doses of NurOwn® will be made available to participants who completed the Expanded Access Protocol
FDA approved EAP manufacturing at the Catalent Texas site
NEW YORK, Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Br... Regenerative Medicine, Neurology, FDA BrainStorm Cell Therapeutics, NurOwn, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2021 Category: Pharmaceuticals Source Type: news
Professional Football Players at Higher Risk for ALS
FRIDAY, Dec. 17, 2021 -- The incidence of and mortality from amyotrophic lateral sclerosis (ALS) among National Football League (NFL) players is nearly four times higher than that of men in the general U.S. population, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2021 Category: Pharmaceuticals Source Type: news
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Sidney A. Spector, MD, PhD, appointed Senior VP, Global Strategy and Medical Affairs
Kim Thacker, MD, appointed Senior VP, Medical Affairs and Clinical Innovation
Stacy Lindborg, PhD, Executive VP, named Chief Development Officer
NEW YORK, Nov. 8,... Biopharmaceuticals, Neurology, Personnel BrainStorm Cell Therapeutics, NurOwn, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2021 Category: Pharmaceuticals Source Type: news
Lipid Levels Tied to ALS Risk Lipid Levels Tied to ALS Risk
Elevated levels of high-density lipoprotein are associated with reduced risk for amyotrophic lateral sclerosis (ALS); higher total cholesterol to HDL ratio is linked to increased risk for ALS.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 14, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
An ALS Drug Shows Early Promise Against Alzheimer's
MONDAY, Aug. 2, 2021 -- Could a drug used to treat amyotrophic lateral sclerosis (ALS) help people with mild Alzheimer ' s disease?
The results of a small new study suggest the strategy could work.
Riluzole has been used for more than 20 years to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 2, 2021 Category: General Medicine Source Type: news
ALS Drug Riluzole Shows Early Promise Against Alzheimer's
MONDAY, Aug. 2, 2021 -- Could a drug used to treat amyotrophic lateral sclerosis (ALS) help people with mild Alzheimer ' s disease?
The results of a small new study suggest the strategy could work.
Riluzole has been used for more than 20 years to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 2, 2021 Category: General Medicine Source Type: news
How COVID-19 Long Haulers Could Change the U.S. Disability Benefits System
When COVID-19 began spreading in the U.S. in March 2020, McKale Santin was working at a nursing home in Burlington, Vermont. She and her coworkers didn’t yet know how deadly the virus would become, but she remembers feeling nervous as the first patients got sick and she was asked to examine them with only a surgical mask, not the more protective N95 mask that she wore to test for conditions like tuberculosis.
One day, a patient pulled down her own mask to sneeze while Santin was conducting a respiratory assessment. Soon after, the woman became one of Vermont’s first people to die from COVID-19—and Santin...
Source: TIME: Health - July 20, 2021 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 feature Source Type: news
